Serial Lipocalin 2 and Oncostatin M levels reflect inflammation status and treatment response in axial spondyloarthritis

BACKGROUND: Informative serum biomarkers for monitoring inflammatory activity and treatment responses in axial spondyloarthritis (axSpA) are lacking. We assessed whether Lipocalin 2 (LCN2) and Oncostatin M (OSM), both having roles in inflammation and bone remodeling, may accurately reflect chronic j...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsui, Florence W. L., Lin, Aifeng, Sari, Ismail, Zhang, Zhenbo, Tsui, Hing Wo, Inman, Robert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120829/
https://www.ncbi.nlm.nih.gov/pubmed/33990221
http://dx.doi.org/10.1186/s13075-021-02521-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120829/
https://www.ncbi.nlm.nih.gov/pubmed/33990221
http://dx.doi.org/10.1186/s13075-021-02521-y

Ejemplares similares